Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
País como assunto
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Laryngoscope ; 125(8): 1934-9, 2015 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-25703159

RESUMO

OBJECTIVES/HYPOTHESIS: Soft tissue reactions around abutments are the most common complications of percutaneous osseointegrated implants. The main objective of this study was to review our series of osseointegrated implants, evaluate the degree of adverse skin reactions around the auricular abutments, and compare with skin reactions in the pediatric bone-anchored hearing aid (BAHA) population. The reason for comparing these two groups was the difference in abutment shape and position in skin with different characteristics. STUDY DESIGN: A retrospective case analysis of 131 patient notes. METHODS: We retrospectively studied 131 pediatric and adult patients who underwent an osseointegrated auricular prosthesis over a 10-year period (1997-2007). RESULTS: There were 95 adults and 36 children who had been implanted and fitted with an auricular prosthesis during the 10-year study period. All patients were followed up postoperatively for a 2-year minimum up to a 14-year maximum follow-up. Thirteen (13/36, 36%) children and seven adults (7/95, 7%) had a skin reaction around the ear prosthesis. CONCLUSIONS: The literature review has supported our study results and has shown that children have higher skin reactions in both BAHA and auricular prostheses than adults. Adverse skin reactions in the pediatric auricular group were significantly lower that the pediatric BAHA group. LEVEL OF EVIDENCE: 4


Assuntos
Orelha Externa/cirurgia , Previsões , Auxiliares de Audição , Próteses e Implantes , Pele/patologia , Lesões dos Tecidos Moles/etiologia , Titânio , Adulto , Criança , Feminino , Seguimentos , Humanos , Incidência , Masculino , Complicações Pós-Operatórias , Estudos Retrospectivos , Lesões dos Tecidos Moles/diagnóstico , Reino Unido/epidemiologia
2.
Expert Opin Pharmacother ; 8(9): 1337-44, 2007 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-17563267

RESUMO

Benign prostatic hyperplasia is an increasingly prevalent condition affecting > 50% of men > 65 years of age. Although it is a condition that is unlikely to be life threatening, it can significantly affect quality of life with distressing lower urinary tract symptoms. Increasingly, medical therapy is being used as first-line treatment for men with moderate-to-severe lower urinary tract symptoms. Two main pharmacological classes of drugs are used: 5alpha-reductase inhibitors and alpha-1 selective blockers. Both these classes of drugs have shown good tolerability and clinical efficacy. This article examines the potential benefit of the use of combination therapy. In particular, what is the evidence for using doxazosin and finasteride therapy together?


Assuntos
Antagonistas Adrenérgicos alfa/uso terapêutico , Doxazossina/uso terapêutico , Inibidores Enzimáticos/uso terapêutico , Finasterida/uso terapêutico , Hiperplasia Prostática/tratamento farmacológico , Inibidores de 5-alfa Redutase , Antagonistas Adrenérgicos alfa/administração & dosagem , Idoso , Doxazossina/administração & dosagem , Quimioterapia Combinada , Inibidores Enzimáticos/administração & dosagem , Finasterida/administração & dosagem , Humanos , Masculino
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa